ENA Respiratory has begun dosing participants in Part B of [...]

CONNECTA Therapeutics will present preclinical data supporting its Phase 2a [...]

Remepy has published new peer-reviewed findings showing that its investigational [...]

Medicus Pharma has submitted an investigational new drug application in [...]

CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]

Cereno Scientific has completed the last patient’s last visit in [...]

BiPER Therapeutics has raised €1 million ($1.16M) to support the [...]

Skye Bioscience has reported topline results from its Phase 2a [...]

InflaRx has reported its Q2 2025 results and provided updates [...]

Ethris has dosed the first patient in a Phase 2a [...]